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Objective. In pursuance of thoroughly understanding and facilitating the evaluation of the radiological changes in the preloaded
bone by Compliant Pre-Stress osseointegration (Compress Biomet, Warsaw, Indiana) a new staging method was created depicting
four stages.Methods. Two cohorts (10 and 17 patients resp., not-receiving and receiving chemotherapy) were compared in terms of
progression of osseointegration. Based on the changes at the bone-metal interface seen on ro¨ntgenorgrams four stages were defined:
stage 0: immediate postoperative status, no ingrowth, or noncalcified callus; stage 1: early mineralization, calcified callus; stage 2:
mature mineralization; and stage 3: hypertrophy at the level of the pins. Results. There were no significant differences between the
two cohorts. Group 2, which was significantly younger than group 1 (𝑝 < 0.001), presented a delayed initial rate of bone formation
and reached stage 1 at 6 months instead of 3 months like group 1. The children from the group 2 demonstrated a visible rebound
ingrowth.Conclusion. Despite the fact that the staging fails to demonstrate a statistical difference, it is rather simple and can be used
for future studies.
1. Introduction
Due to the improved imaging techniques and chemother-
apy regimens nowadays, limb sparing procedures become
the mainstay of treatment of primary bone tumors [1].
Unfortunately, the long term results of classic long-stem
endoprosthetic reconstructions (cemented or uncemented)
are poor due to loosening and/or stress shielding, displaying
a survival rate of 83 percent at five years and only 67 percent
at ten years [2]. As the patient population is generally young,
major revisions are required to restore a stable fixation,
associated with additional bone loss [3, 4]. Stems with
a coated collar allowing active bone ingrowth proved to
provide a better fixation on the long term [5–7]. Dynamic
compression fixation (Compress) of tumor prostheses was
proposed as an alternative to long stems, aiming to improve
the long term survivorship of the implant through active
osseointegration. By using a short traction bar the ongoing
compressive force generated by Belleville washers stimulates
osseointegration at the bone-prosthetic interface [8, 9] and
promotes hypertrophy of the loaded bone. In literature cur-
rently no radiographic scoring system is available to evaluate
the ingrowth and the bone hypertrophy in a straightforward
way. For instance, the ISOLS radiographic scoring system is
not applicable to this kind of fixation [10]. For the purpose
of easier and proper radiologic evaluation and comparison, a
new staging method was developed.
2. Study Design and Methods
Between 2006 and 2014 27 patients with distal third femoral
replacements only were included in this study. All interven-
tions were performed in a single university hospital by the
same orthopedic surgeon (GS). A reconstruction prosthesis
(OSS, Biomet, Warsaw, Indiana) was used in all patients,
fixed to the bone by a Compress device. All patients had
an initial resection of a bone tumor (19 bone sarcomas,
2 giant cell tumors of bone, and 2 soft tissue sarcomas
affecting the bone). Ten patients (group 1) did not receive
chemotherapy at least 1 year before the surgical intervention.
Sixteen patients (group 2) received neoadjuvant and adjuvant
chemotherapy according to the EURAMOS [11] and one
Euro-Ewing protocol [12].
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Table 1: Demographic information.
Age at Gender Diagnosis Bone Location Type
surgery soft tissue bone resection
1 10 Female 3,5 years tumor-free, leg length discrepancy Bone Femur Total knee
2 31 Female 14 year tumor-free, femoral loosening Bone Femur Total knee
3 33 Male 9 year tumor-free, infection Bone Femur Total knee
4 41 Male 22 y tumor-free, loosening tumorprothese knee replacement Femur Total knee
5 40 Female Leiomyosarcoma Bone Femur Total knee
6 65 Female Leiomyosarcoma Soft tissue Femur Total knee
7 38 Male Giant cell Bone Femur Total knee
8 63 Female Giant cell Bone Femur Total knee
9 57 Female Chondrosarcoma Bone Femur Total knee
10 68 Male Chondrosarcoma Bone Femur Total knee
1 7 Male Osteosarcoma Bone Femur Total knee
2 9 Female Osteosarcoma Bone Femur Total knee
3 11 Male Osteosarcoma Bone Femur Total knee
4 11 Female Osteosarcoma Bone Femur Total knee
5 12 Male Osteosarcoma Bone Femur Total knee
6 14 Female Osteosarcoma Bone Femur Total knee
7 14 Female Osteosarcoma Bone Femur Total knee
8 14 Male Osteosarcoma Bone Femur Total knee
9 15 Female Osteosarcoma Bone Femur Total knee
10 16 Male Osteosarcoma Bone Femur Total knee
11 16 Female Osteosarcoma Bone Femur Total knee
12 17 Female Osteosarcoma Bone Femur Total knee
13 19 Male Osteosarcoma Bone Femur Total knee
14 19 Female Osteosarcoma Bone Femur Total knee
15 22 Male Ewing sarcoma Bone Tibia Total knee
16 26 Male Osteosarcoma Bone Femur Total knee
17 30 Female Osteosarcoma Bone Femur Total knee
The treatment was coordinated by a multidisciplinary
oncological team specialized in sarcoma treatment. Demo-
graphics and diagnoses are presented in Table 1.
The mean follow-up for patients enrolled in the study
was 36 months (median 34 months, range 15–66 months).
During the study one patient had an amputation because
of full thickness flap failure at 2 months. Another one
developed early postop infection treated with debridement
and irrigation. The age distribution was 9–68 years mean 27;
there were 15 females and 12 males. Data were collected up
to 18 months postoperatively. The mean resection length was
15 cm (median 16 cm, range 8–26 cm). Only cases of femoral
osseointegration were included, in Table 2.
Radiological assessment (standard AP and lateral view)
took place immediately after the operation. Afterwards office
visits were scheduled for clinical evaluation and radiographs
at 6 weeks, 3, 6, 9, 12, 15, and 18 months after surgery. No
patients were recalled specifically for the study. The radio-
graphs were taken before the consultation and afterwards
coded without names and dates by the study nurse. The
radiographic evaluation was performed independently by
two orthopedic surgeons according to the new staging system
and was repeated three times.
For the staging system four radiological stages were
defined: stage 0: immediate postoperative status, no in-
growth, or noncalcified callus; stage 1: early mineralization,
calcified callus; stage 2: mature mineralization; and stage 3:
hypertrophy at the level of the pins, as in Figure 1.
The Medical Ethics Committee granted approval for
the study and informed consent was obtained from all the
patients or their parents.
2.1. Surgical Technique. After en bloc removal of the tumor,
a standard technique for prosthetic reconstruction was used
as recommended by the manufacturer [8, 9]. Shortly, during
the preparation of the diaphyseal bone special attention was
taken to protect the blood supply in the bone-prosthesis
interface region by minimal reaming and protecting the
periosteal membrane. Subsequently the anchor plug and
traction bar were secured to the cortical bone via transverse
pins. The spindle containing the Belleville washers was
attached to the traction bar by means of a nut, resulting in
a compression of the spindle to the bone. The compression
force used, depending on the cortical width, varied between
600 and 800 lb. (181–363 kg) and serves to promote bone
ingrowth at the bone-prosthetic interface and to induce
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Table 2:The summary of the demographic characteristics of the two
groups.
Characteristic Value
Number of patients 27
Compress fixed 27
Follow-up Mean 36 months(range 15–66)
Male 12 (45.5%)
Female 15 (55.5%)
Age at surgery
Nonchemo Mean 45, median41 (range 10–65)
Chemo Mean 16, median15 (range 9–30)
𝑝 value 0.000377663
Length of resection
Nonchemo Median 13.8 (range8–23.5)
Chemo Median 15.3 (range8–23.5)
𝑝 value 0.303972
Children (growing potential at surgery) 9 (33.3%)
Adults treated with chemotherapy 8 (29.6%)
Adults not treated with chemotherapy 10 (37%)
Diagnosis
Osteosarcoma 16 (59.2%)
Ewing sarcoma 1 (3.7%)
Chondrosarcoma, giant cell, and
leiomyosarcoma 2 (7.4%)
Revision
Loosening 2 (7.4%)
3,5 years tumor-free, leg length discrepancy 1 (3.7%)
9 year tumor-free, infection 1 (3.7%)
bone hypertrophy according to Wolff ’s Law. Two or three
antirotational pins were used to avoid loosening of the device
by rotational forces. These pins were available since the end
of 2011, not before.
Rehabilitation encompassing active-assisted and gentle
active range of motion among with muscle strengthening
exercises was initiated immediately after surgery. A strict
nonweight bearing protocol was recommended until the
radiographs showed early callus mineralization (stage 1),
after which partial weight bearing was allowed and grad-
ually increased. Activities creating rotational torque such
as kneeling, crossing the legs, and squatting were obviated
but cycling and swimming were allowed. Repetitive or high
impact activities were strictly prohibited.
2.2. Statistical Analysis. Student’s 𝑡-test was performed using
SPSS1 Version 22, 2013 (SPSS Inc., Chicago, IL, USA). Inter-
and intraobserver variation was tested with Intraclass Corre-
lation Coefficient (ICC 2.1) evaluating blinded radiographs.
The null hypothesis was that age, location, and chemo-
therapy did not affect ingrowth significantly. A 𝑝 value less
than 0.05 was considered to be statically significant.
3. Results
The study included a total of 27 patients who completed the
study. Group 2 was statistically younger than group 1 (𝑝 =
0.0003811). Aswementioned above a radiological assessment
took place at every visit at preset time intervals (0 and 6weeks
and 3, 6, 9, 12, 15, and 18 months postoperatively). When
defining the ingrowth stages there was neither interobserver
nor intraobserver variability, ICC 2.1 consistency of 1.
Furthermore during the radiographic evaluation signs
of loosening were sought as previously suggested in litera-
ture [6] fracture, transverse pin migration, and progressive
radiolucency at the bone-prosthetic interface. The length of
the visible part of the traction bar was measured and also
the angle between the anchor and the spindle in order to
exclude collapse, indicating loss of compression force. A
fracture line was seen in this area in one patient after a fall
at home one year after surgery. A diminished distance as
well as an angulation between the spindle and the anchor
plug was noted (Figure 2). The patient was closely observed:
no fracture displacement was seen after one year, but the
radiographic assessment showed no progression from stage
2 to stage 3.
For all patients stage 1 was generally reached at 6 months,
stage 2 at 9 months, and stage 3 at 12 months. At 18 months all
patients but three had reached stage 3. One of them has been
just described above (Figure 2). Another one from group
2 showed progression and received longer chemotherapy
and resection of pulmonary metastases. Interestingly, the
third patient who was revised for an infected megaprosthesis
using a Compress system reached stage 3 ingrowth by 18
months despite reinfection and two-time debridement. In
one patient from group 1 palliative chemotherapy was started
after 16 months after reaching stage 3. From the patients with
remaining growing potential there was one child who had
a revision of a long stem of the femur who did not receive
chemotherapy.
There was neither stress shielding nor osteonecrosis nor
transverse pin migration in this study. Other complications
irrelevant to the study were also noted.
In our institution ultrasound is used for the local follow-
up aiming at detection of local tumor recurrence in the
proximity of large prosthetic implants. During the early
stages an intense hypervascular aspect at the bone-prosthetic
interface is observed. This phenomenon is also very distinct
in a Technetium bone scan. Furthermore, callus formation
should not be confused with heterotopic ossification, as seen
in Figure 3.
The data were scrutinized in order to evaluate the effect
of age and chemotherapy on the time interval on which
patients reach the next stage of ingrowth. Statistically there
was no significant difference between the two groups (𝑝 >
0.05). Eventually the patients with still growing potential
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Stage 0: no ingrowth or 
noncalcified callus
(a)
Stage 1: early mineralization
/calcified callus
(b)
Stage 2: mature 
mineralization
(c)
Stage 3: bone hypertrophy 
at the level of the pins
(d)
Figure 1: Radiographic stages of osseointegration according to the new assessment system.
R
(a) (b)
(c) (d)
Figure 2: (a) and (b) Radiolucent line in the compress area after falling 1 y postop, (c) and (d) development of angulation and loss of distance
between the anchor plug and the spindle can be observed after fracture (d) healing when compared to the prefracture X-ray (c). At 18 months
stage 3 has not been reached (d).
BioMed Research International 5
Figure 3: Heterotopic ossification seen at 6 months postop.
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Figure 4: Four graphs representing the effect of chemotherapy and age on the stage. (a) Patients not receiving chemotherapy. (b) Patients
receiving chemotherapy demonstrate a long plateau stage 0 with delayed onset of bone formation at 6 months. When comparing the children
and adults from this group (charts (c) and (d)) a rebound ingrowth and shorter period between stages 2 and 3 and reaching stage 3 earlier are
observed.
from group 2 were compared with the rest of the group and
also group 1. A cut-off of 15 years at the time of surgery was
chosen.The𝑝 valueswere still above 0.05.Thenull hypothesis
was not rejected.
When the effect of chemotherapy and age were charted,
it seemed that patients receiving chemotherapy generally
reached stage 1 at a later time point (6 months instead of 3
months). When children were compared to young adults in
the chemotherapy group, it seemed that children displayed
a rebound ingrowth after cessation of chemotherapy resulting
in a shorter period between stages 2 and 3 and reaching stage
3 at an earlier time point, as shown in Figure 4.
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4. Discussion
Dynamic compressive fixation of tumor prosthesis is a meth-
od introduced to the orthopedic surgery aiming to achieve
biomechanical stable and durable implants while stimulating
osseointegration. In literature there is currently no universal
method describing bone remodeling and ingrowth following
Compress fixation. Fracture callus measurement is also not
an easy task [13] and is therefore not routinely used in
daily practice. Avedian et al. [14] used digital calipers on
standardized radiographs to measure the bone width. In our
opinion this method is cumbersome and hard to reproduce
when it comes to a multicenter research trial.
For this reason a new algorithm was proposed by the
senior author of the group, which seems to be quite easy
and straightforward. However, correct assessment of osseoin-
tegration also has a learning curve. When the ultrasound
specialist is not familiar with the device, the image obtained
during the development of the uncalcified callus may be
misdiagnosed as a local recurrence due to the hypervascular
aspect at the bone-prosthetic interface. The same is true for
a Tc bone scan. Furthermore, callus formation should not be
confused with heterotopic ossification as seen.
The authors have not observed the development of bone
hypertrophy before stages 1 (early mineralization) and 2
(mature mineralization) have been reached. Apparently bone
hypertrophy, a phenomenon observed at the periosteal side
as well as at the endosteal side, is a slow continuous process,
possibly starting at the samemoment as the osseointegration,
but this is hard to discern on radiographs. Full development
of stage 3 was seen only in the femur but not in the tibia or in
the humerus, which is a phenomenon we cannot explain.
We have observed a cessation of bone hypertrophy
towards stage 3 after loss of compression force due to a
fracture.This indicates the usefulness of a staged radiographic
assessment for studying the influence of certain factors such
as chemotherapy on the bone formation at the prosthetic
interface. Although it is a small study and far from represen-
tative, we were able to demonstrate that, after the cessation
of chemotherapy, progressive bone ingrowth is initiated. The
negative effect of chemotherapy on bone metabolism has
been well demonstrated in the literature. The impact of
chemotherapy on graft healing was described in animal [15–
18] and human [19] studies showing an increase of delayed
union.
When it comes to osseointegration Avedian et al. ob-
served a decrease in the absolute amount and the rate of bone
hypertrophy in the group receiving chemotherapy. In our
study we could demonstrate a trend towards a slower onset
of stage 1 in patients receiving chemotherapy, but eventually
almost all patients reach stage 3. Lack of significance is our
opinion due to limited number of patients and diversity
of the groups. Different local factors such as blood supply,
preserving the intraosseous and small periosteal vessels,
irrigation avoiding thermal necrosis, and soft tissue coverage
are crucial elements during surgery. Osteonecrosis of the
bone at the bone-Compress interface can be an important
complication as mentioned by Healey et al. [7], but this
phenomenon was not observed in our patient group.
5. Conclusion
This paper describes a newmethodology for the radiographic
assessment of compressive osseointegration for the fixation of
reconstruction prostheses after tumor resection. The appli-
cation of the method is easy, allowing international com-
parison of prosthetic survival after Compress implantation.
The authors propose to use this evaluation method also for
studying factors delaying or preventing bone hypertrophy
at the prosthetic interface such as age and chemotherapy
regimen, causing prosthetic failure.
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